✦ LIBER ✦

554 POSTER Pharmacokinetic (PK) and pharmacodynamic (PD) results of Phase I studies of IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid malignancies

✍ Scribed by M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; A.B. Sandler; E. Rowinsky; C.S. Higano

Book ID: 119599710
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)72488-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

648 POSTER A phase I dose-escalation stu

648 POSTER A phase I dose-escalation study of weekly IMC-A12, a fully human insulin like growth factor-I receptor (IGF-IR) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ C. Higano; M. Gordon; P. LoRusso; F. Fox; T. Katz; J. Roecker; E. Rowinsky; H. Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase 1 study of ganitumab (AMG 479), a

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors

✍ Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 228 KB

647 POSTER A phase I dose-escalation stu

647 POSTER A phase I dose-escalation study of weekly IMC-1121B, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR2) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

406 POSTER IMC-18F1, a recombinant human

406 POSTER IMC-18F1, a recombinant human monoclonal antibody (MAb) against the vascular endothelial growth factor receptor-1 (VEGFR-1), in the treatment of patients (pts) with advanced solid malignancies: A Phase 1 study

✍ S. Krishnamurthi; P.H.B. Goncalves; F. Fox; N. Hall; E. Rowinsky; J. Schwartz; H 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Phase I Pharmacokinetic and Pharmacodyna

Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

✍ Paz-Ares, L. G.; Gomez-Roca, C.; Delord, J.-P.; Cervantes, A.; Markman, B.; Corr 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

196 POSTER A phase I trial incorporating

196 POSTER A phase I trial incorporating the pharmacodynamic (PD) study of circulating tumour cells (CTC) of CP-751,871 (C), a monoclonal antibody against the insulin-like growth factor 1 receptor (IGF-1R), in combination with docetaxel (D) in patients (p) with advanced cancer

✍ P.C. Fong; R.L. Molife; J. Spicer; T.A. Yap; S. Settatree; L. Digue; G. Attard; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 71 KB